EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES

被引：7
|
作者：
Morand, E. F. [1 ]
Tanaka, Y. [2 ]
Furie, R. [3 ,4 ]
Vital, E. [5 ]
van Vollenhoven, R. [6 ]
Kalunian, K. [7 ]
Mosca, M. [8 ]
Doerner, T. [9 ]
Wallace, D. J. [10 ]
Silk, M. [11 ]
Dickson, C. [11 ]
De la Torre, I. [11 ]
Meszaros, G. [11 ]
Jia, B. [11 ]
Crowe, B. [11 ]
Petri, M. A. [12 ]
机构：
[1] Monash Univ, Ctr Inflammatory Dis, Melbourne, Australia
[2] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Japan
[3] Northwell Hlth, New Hyde Pk, NY USA
[4] Northwell, Zucker Sch Med, Div Rheumatol, New Hyde Pk, NY USA
[5] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England
[6] Univ Med Ctr, Clin Immunol & Rheumatol, Amsterdam, Netherlands
[7] Univ Calif La Jolla, Div Rheumatol Allergy & Immunol, La Jolla, CA USA
[8] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[9] Charite, Dept Med Rheumatol & Clin Immunol, Berlin, Germany
[10] Univ Calif Los Angeles, Cedars Sinai Med Center, Div Rheumatol Allergy & Immunol, Los Angeles, CA USA
[11] Eli Lilly & Co, NIA, Indianapolis, IN USA
[12] Johns Hopkins Univ, Div Rheumatol, Sch Med, Baltimore, MD USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.1968
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0190
引用
收藏
页码：327 / 328
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study
    Li, Yanpeng
    Zhang, Ruoxi
    Zhou, Yanling
    Bao, Cungang
    Lin, Zhaocun
    Chen, Chunyan
    He, Jingjing
    Jin, Zhiping
    Song, Lihua
    Zhang, Min
    Guo, Sigen
    Jiang, Yu
    Zhao, Zhongxin
    SLEEP, 2024, 47 (02)
  • [22] Efficacy and Safety of Cenerimod in Patients with Moderate to Severe Systemic Lupus Erythematosus (SLE): A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2b Trial
    Askanase, Anca
    Berkani, Ouali
    Cahuzac, Clelia
    Cornelisse, Peter
    D'Cruz, David
    Kalunian, Kenneth
    Merrill, Joan
    Pozzobon, Marilia
    Navarra, Sandra
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3293 - 3297
  • [23] Efficacy and Safety of Dupilumab in Patients From China With Persistent Asthma: A Subgroup Analysis of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study
    Zhang, Q.
    Zhong, N.
    Fang, H.
    Zhu, S.
    Wang, Z.
    Zhao, L.
    Laws, E.
    Mannent, L.
    Wang, Y.
    Li, V.
    Li, A.
    Hu, C.
    Lederer, D. J.
    Abdulai, R. M.
    Robinson, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [24] The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study
    Gerhardsen, Gerhard
    Hansen, Anne V.
    Killi, Marianne
    Fornitz, Gitte Gleerup
    Pedersen, Frank
    Roos, Signe Barfod
    ADVANCES IN THERAPY, 2008, 25 (06) : 595 - 607
  • [25] The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study
    Gerhard Gerhardsen
    Anne V. Hansen
    Marianne Killi
    Gitte Gleerup Fornitz
    Frank Pedersen
    Signe Barfod Roos
    Advances in Therapy, 2008, 25
  • [26] Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme
    Bugarski-Kirola, Dragana
    Iwata, Nakao
    Sameljak, Snjezana
    Reid, Carol
    Blaettler, Thomas
    Millar, Laurie
    Marques, Tiago Reis
    Garibaldi, George
    Kapur, Shitij
    LANCET PSYCHIATRY, 2016, 3 (12): : 1115 - 1128
  • [27] A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis
    Cheng, Laurence E.
    Amoura, Zahir
    Cheah, Benjamin
    Hiepe, Falk
    Sullivan, Barbara A.
    Zhou, Lei
    Arnold, Gregory E.
    Tsuji, Wayne H.
    Merrill, Joan T.
    Chung, James B.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (07) : 1071 - 1076
  • [28] Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study
    Inoue, Yuichi
    Shimizu, Tetsuo
    Hirata, Koichi
    Uchimura, Naohisa
    Ishigooka, Jun
    Oka, Yasunori
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    SLEEP MEDICINE, 2013, 14 (11) : 1085 - 1091
  • [29] Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial
    Marconi, Vincent C.
    Ramanan, Athimalaipet, V
    de Bono, Stephanie
    Kartman, Cynthia E.
    Krishnan, Venkatesh
    Liao, Ran
    Piruzeli, Maria Lucia B.
    Goldman, Jason D.
    Alatorre-Alexander, Jorge
    Pellegrini, Rita de Cassia
    Estrada, Vicente
    Som, Mousumi
    Cardoso, Anabela
    Chakladar, Sujatro
    Crowe, Brenda
    Reis, Paulo
    Zhang, Xin
    Adams, David H.
    Ely, E. Wesley
    LANCET RESPIRATORY MEDICINE, 2021, 9 (12): : 1407 - 1418
  • [30] A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
    Schmidt, Wolfgang A.
    Dasgupta, Bhaskar
    Luqmani, Raashid
    Unizony, Sebastian H.
    Blockmans, Daniel
    Lai, Zhihong
    Kurrasch, Regina H.
    Lazic, Ivana
    Brown, Kurt
    Rao, Ravi
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 793 - 810
12345